0001071955-05-000077.txt : 20120625
0001071955-05-000077.hdr.sgml : 20120625
20050411145508
ACCESSION NUMBER: 0001071955-05-000077
CONFORMED SUBMISSION TYPE: SC 13G
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20050411
DATE AS OF CHANGE: 20050411
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: DUSA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000879993
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 223103129
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
SEC ACT: 1934 Act
SEC FILE NUMBER: 005-42248
FILM NUMBER: 05743806
BUSINESS ADDRESS:
STREET 1: 25 UPTON DRIVE
CITY: WILMINGTON
STATE: MA
ZIP: 01887
BUSINESS PHONE: 9786577500
MAIL ADDRESS:
STREET 1: 25 UPTON DRIVE
CITY: WILMINGTON
STATE: MA
ZIP: 01887
FORMER COMPANY:
FORMER CONFORMED NAME: DEPRENYL USA INC / NJ
DATE OF NAME CHANGE: 19930328
FILED BY:
COMPANY DATA:
COMPANY CONFORMED NAME: PEQUOT CAPITAL MANAGEMENT INC
CENTRAL INDEX KEY: 0001071955
IRS NUMBER: 061524885
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: SC 13G
BUSINESS ADDRESS:
STREET 1: 500 NYALA FARM ROAD
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: 2034292200
MAIL ADDRESS:
STREET 1: 500 NYALA FARM ROAD
CITY: WESTPORT
STATE: CT
ZIP: 06880
FORMER COMPANY:
FORMER CONFORMED NAME: PEQUOT CAPITAL MANAGEMENT INC/CT/
DATE OF NAME CHANGE: 19981118
SC 13G
1
dusa.txt
DUSA PHARMACEUTICALS 13G 2005-03-03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
Amendment No.:
Name of Issuer: DUSA PHARMACEUTICALS, INC.
Title of Class of Securities: COMMON STOCK NO PAR VALUE
CUSIP Number: 266898105
Date of Event Which Requires Filing of This Statement: March 3, 2005
Check the appropriate box to designate the rule pursuant
to which this Schedule is filed:
[x] Rule 13d-1(b)
[ ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
1. Name of Reporting Person and S.S. or I.R.S. Identification
No of Above Person: Pequot Capital Management, Inc.
Tax ID: 06-1524885
2. Check the Appropriate Box if a Member of a Group
a.
b.
3. SEC Use Only
4. Citizenship or Place of Organization:
Connecticut
Number of Shares Beneficially Owned by Each Reporting Person With:
5. Sole Voting Power: 1,663,700
6. Shared Voting Power: 0
7. Sole Dispositive Power: 1,711,400
8. Shared Dispositive Power: 0
9. Aggregate Amount Beneficially Owned by Each Reporting Person:
1,711,400
10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares:
11. Percent of Class Represented by Amount in Row (9): 10.12%
12. Type of Reporting Person: IA, CO
Item 1(a) Name of Issuer: DUSA PHARMACEUTICALS, INC.
1(b) Address of Issuer's Principal Executive Offices:
25 UPTON DRIVE, WILMINGTON, MA 01887
Item 2(a)-(c). Name, Principal Business Address, and Citizenship of Persons
Filing:
Pequot Capital Management, Inc., 500 Nyala Farm Road, Westport,
CT, 06880, which is a Connecticut corporation.
(d) Title of Class of Securities: COMMON STOCK NO PAR VALUE
(e) CUSIP Number: 266898105
Item 3. This statement is filed pursuant to Rule 13d-1(b)(1)(ii)(E).
Pequot Capital Management, Inc. is an investment adviser registered
under Section 203 of the Investment Advisers Act of 1940.
Item 4. Ownership.
Ownership as of March 3, 2005 is incorporated herein by
reference from items (5) - (9) and (11) of the cover page of the
Reporting Person.
Item 5. Ownership of Five Percent or Less of a Class.
Not applicable.
Item 6. Ownership of More than Five Percent on Behalf of Another Person.
The reporting person is an investment adviser registered under Section
203 of the Investment Advisers Act of 1940 and, as such, has beneficial
ownership of the shares which are the subject of this filing through
the investment discretion the reporting person exercises over its
clients' accounts.
Item 7. Identification and Classification of the Subsidiary Which Acquired the
Security Being Reported by the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of the Group.
Not applicable.
Item 10.
By signing below, I certify that, to the best of my knowledge and belief, the
Securities referred to above were acquired in the ordinary course of business
and were not acquired for the purpose and do not have the effect of changing or
influencing the control of the issuer of such securities and were not acquired
in connection with or as a participant in any transaction having such purpose
or effect.
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Date: April 11, 2005
By: /s/ Aryeh Davis
Title: Chief Operating Officer, General Counsel and Secretary